KR880003956A - 신규 세팔로스포린 화합물 - Google Patents

신규 세팔로스포린 화합물 Download PDF

Info

Publication number
KR880003956A
KR880003956A KR870010622A KR870010622A KR880003956A KR 880003956 A KR880003956 A KR 880003956A KR 870010622 A KR870010622 A KR 870010622A KR 870010622 A KR870010622 A KR 870010622A KR 880003956 A KR880003956 A KR 880003956A
Authority
KR
South Korea
Prior art keywords
compound
group
salts
formula
iii
Prior art date
Application number
KR870010622A
Other languages
English (en)
Korean (ko)
Inventor
얼 뉴올 크리스토퍼
에드가 루커 브라이언
Original Assignee
원본미기재
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868623212A external-priority patent/GB8623212D0/en
Priority claimed from GB878705986A external-priority patent/GB8705986D0/en
Application filed by 원본미기재, 글락소 그룹 리미티드 filed Critical 원본미기재
Publication of KR880003956A publication Critical patent/KR880003956A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR870010622A 1986-09-26 1987-09-25 신규 세팔로스포린 화합물 KR880003956A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8623212 1986-09-26
GB868623212A GB8623212D0 (en) 1986-09-26 1986-09-26 Chemical compounds
GB878705986A GB8705986D0 (en) 1987-03-13 1987-03-13 Chemical compounds
GB8705986 1987-03-13

Publications (1)

Publication Number Publication Date
KR880003956A true KR880003956A (ko) 1988-05-31

Family

ID=26291340

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870010622A KR880003956A (ko) 1986-09-26 1987-09-25 신규 세팔로스포린 화합물

Country Status (21)

Country Link
KR (1) KR880003956A (de)
AT (1) ATA244087A (de)
AU (1) AU607937B2 (de)
BE (1) BE1002248A5 (de)
CH (1) CH676850A5 (de)
DE (1) DE3732457A1 (de)
DK (1) DK503787A (de)
ES (1) ES2008739A6 (de)
FI (1) FI874211A (de)
FR (1) FR2604437A1 (de)
GB (1) GB2197649B (de)
GR (1) GR871487B (de)
HU (1) HU201946B (de)
IL (1) IL83993A0 (de)
IT (1) IT1221510B (de)
LU (1) LU87002A1 (de)
NL (1) NL8702295A (de)
NO (1) NO874044L (de)
PH (1) PH25299A (de)
PT (1) PT85792B (de)
SE (1) SE8703701L (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0400805A1 (de) * 1989-04-25 1990-12-05 Toshiyasu Ishimaru Cephalosporinverbindungen und ihre Verwendung
KR970005896B1 (ko) * 1993-07-23 1997-04-21 주식회사 엘지화학 신규 세팔로스포린계 항생제 및 그의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432521A1 (fr) * 1978-03-31 1980-02-29 Roussel Uclaf Nouvelles oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS6011917B2 (ja) * 1981-04-09 1985-03-28 山之内製薬株式会社 新規なセファロスポリン化合物
AU586229B2 (en) * 1985-04-01 1989-07-06 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS62167784A (ja) * 1985-07-27 1987-07-24 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤

Also Published As

Publication number Publication date
ES2008739A6 (es) 1989-08-01
GR871487B (en) 1988-02-04
NL8702295A (nl) 1988-04-18
IT8748421A0 (it) 1987-09-25
CH676850A5 (de) 1991-03-15
AU607937B2 (en) 1991-03-21
GB2197649B (en) 1990-03-28
IT1221510B (it) 1990-07-06
NO874044L (no) 1988-03-28
DK503787A (da) 1988-03-27
GB8722574D0 (en) 1987-11-04
IL83993A0 (en) 1988-02-29
HU201946B (en) 1991-01-28
PH25299A (en) 1991-04-30
DK503787D0 (da) 1987-09-25
FR2604437A1 (fr) 1988-04-01
AU7896087A (en) 1988-03-31
FI874211A (fi) 1988-03-27
SE8703701D0 (sv) 1987-09-25
PT85792A (en) 1987-10-01
DE3732457A1 (de) 1988-03-31
BE1002248A5 (fr) 1990-11-06
GB2197649A (en) 1988-05-25
LU87002A1 (fr) 1988-03-02
FI874211A0 (fi) 1987-09-25
PT85792B (pt) 1990-08-31
SE8703701L (sv) 1988-03-27
ATA244087A (de) 1991-02-15
HUT45539A (en) 1988-07-28
NO874044D0 (no) 1987-09-25

Similar Documents

Publication Publication Date Title
TW222588B (de)
KR890005124A (ko) 세펨 화합물 및 이의 제조방법
SE7612053L (sv) Forfarande for framstellning av enolderivat
KR860006479A (ko) 신규의 디사카라이드 및 트리사카라이드 유도체의 제조방법
IE780899L (en) Azetidinopyrrole derivatives
MD247C2 (ro) Procedeu de obţinere a formei hidratate cristaline a sării de sodiu a acidului 3-acetoximetil-7-[2-(2-amino-4-tiazolil)-2-metoxiiminoacetamido] -cef-3-em-4-carbonic, a sin-izomerului
KR840007731A (ko) 세팔로스포린 화합물의 제조방법
KR880003956A (ko) 신규 세팔로스포린 화합물
KR830007683A (ko) 7β-[2-(2-아미노-4-티아졸릴)-2-(신)-메톡시 아미노 아세트 아미도]-3-세펨-4-카복실산의 에스테르의 제조방법
NZ220195A (en) 2-pyridyl-penem derivatives and pharmaceutical compositions
PT95949A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de 1h-azol-omega-{4-(2-pirimidinil)-1-piperazinil}-alquilo apropriadas para o tratamento de perturbacoes associadas ao sindroma de abstinencia induzido pela supressao de benzodiazepinas
NZ234270A (en) Muramyl dipeptide derivatives and pharmaceutical compositions
KR890002174A (ko) 삼환성 세팜 화합물, 그의 제조방법 및 용도
KR940003961A (ko) 신규 세팔로스포린계 항생제 및 이의 제조방법
KR880011109A (ko) 치환된 테트라하이드로이소퀴놀린 화합물, 이의 제조방법 및 이를 함유하는 조성물
KR930023328A (ko) N-메틸데아세틸콜히세인아미드 유도체
KR890003779A (ko) β-락탐 화합물, 이 화합물의 제조방법, 이 화합물의 합성용 중간체 및 이 화합물을 함유하는 세균감염 질환 치료용 의약조성물
KR920008050A (ko) 세펨 화합물, 이의 제조방법 및 항균제
KR830001954A (ko) 세팔로스포린 항생제
KR870008895A (ko) 세팔로스포린 유도체, 그의 제조 방법 및 항균 제제
KR850700244A (ko) 세팔로스포린 유도체 및 그 염의 제조방법
KR900003178A (ko) 세펨 화합물의 제조방법
JPS5515454A (en) Novel cephalosporin derivative
KR850007428A (ko) 세파로스포린 화합물의 제조방법
EP0098161A3 (de) Cephalosporinderivate

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid